Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Moderna, Inc. - Common Stock (NQ:MRNA)

29.49 -0.92 (-3.03%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Moderna, Inc. - Common Stock

< Previous 1 2
...
24 25 26 27 28 29 30 31 32
...
99 100 Next >
News headline image
MODERNA, INC. (NASDAQ: MRNA) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Moderna, Inc. Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
News headline image
DeSantis Administration Cautions Against Pfizer, Moderna mRNA Covid Vaccines for Vulnerable Individuals, Cites Concerns Related To Rare Heart Conditions ↗
Florida advises against mRNA Covid vaccines for vulnerable residents, citing safety concerns. Gov. DeSantis' administration urges healthcare providers to prioritize alternative vaccines for seniors and... 
Via Benzinga
News headline image
Moderna’s Recent Drop: 4 Reasons Bulls See Opportunity
Moderna Inc. (NASDAQ: MRNA) made headlines during the pandemic for its messenger ribonucleic acid (mRNA) technology used in its COVID-19 vaccine Spikevax. 
Via MarketBeat
News headline image
Moderna, Tyson Foods And Adobe Are Among Top 10 Large Cap Stock Losers Last Week (Sep 8-Sep 14): Are The Others In Your Portfolio? ↗
10 worst performing large-cap stocks last week: RTO, ALLY, MRNA, HUM, TSN, BEKE, ADBE, RYAAY, JPM, DVN. Consider impact on your portfolio. 
Via Benzinga
News headline image
16 Analysts Have This To Say About Moderna ↗
 
Via Benzinga
News headline image
Here's How Much You Would Have Made Owning Moderna Stock In The Last 5 Years ↗
 
Via Benzinga
News headline image
Down More Than 50%, Is It Time to Buy Moderna Stock as the Biotech Charts a New Post-COVID Path? ↗
This highflier has fallen on hard times recently. 
Via The Motley Fool
News headline image
Wall Street's Top 10 Stock Calls This Week - Saturday, Sept. 14 ↗
What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the trading week of Sept. 9-13, 2024. 
Via Talk Markets
News headline image
Investing in Biotech or Pharma Stocks? Pay Attention to These 3 Things and You'll Win More ↗
Financial factors aren't the only things that are worth paying attention to. 
Via The Motley Fool
News headline image
After Moderna's Shocking News, Is the Stock a Buy or a Sell? ↗
Moderna held its annual R&D day this week. 
Via The Motley Fool
News headline image
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Moderna, Lululemon, XPEL, and Nano Nuclear and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Tradepulse Power Inflow Alert: Moderna Inc. Rises 8.9% On The Trading Day ↗
 
Via Benzinga
News headline image
Moderna R&D Day Highlights Progress and Strategic Priorities
Via ACCESSWIRE
News headline image
Moderna Faces Analyst Downgrades Amid Revised R&D Restructured Strategy and Delayed Profitability Target ↗
Moderna announces plans to reduce R&D spending by $1.1 billion by 2027, focusing on ten key products. Analysts highlight near-term challenges, lowered price targets, and a delayed breakeven to 2028,... 
Via Benzinga
News headline image
Oracle To Rally Around 23%? Here Are 10 Top Analyst Forecasts For Friday ↗
 
Via Benzinga
News headline image
Moderna's Pain Continues Amid Flurry Of Downgrades Following 'Tough' R&D Day ↗
The company offered a series of updates that shook shares on Thursday. The selloff continued on Friday. 
Via Investor's Business Daily
News headline image
Should You Buy Novavax Stock After This Regulatory Win? ↗
The biotech continues to earn important wins, but is it enough? 
Via The Motley Fool
News headline image
A Bull Market Is Here: 2 High-Potential Stocks Down More Than 50% to Buy Right Now ↗
These players have had their ups and downs -- but the future looks bright. 
Via The Motley Fool
News headline image
Check Out What Whales Are Doing With MRNA ↗
 
Via Benzinga
News headline image
Wall Street Eyes Strong Finish To The Week Despite Futures Suggesting Moderation In Tech Buying: Strategist Cautions Against Factoring Rapid, Steep Cuts Ahead Of Next Week's Fed Meeting ↗
Now that the twin inflation reports are in the rearview mirror, U.S. stocks are hanging onto the slender optimism as traders look ahead to the Federal Reserve’s rate-setting meeting. 
Via Benzinga
Topics Economy
News headline image
Moderna Slashes R&D Budget, Stock Plummets Amid Profitability Concerns ↗
Moderna announced plans to slash its R&D budget by $1.1 billion by 2027. 
Via Talk Markets
News headline image
Why Are Novavax Shares Trading Lower Today? ↗
Novavax Inc. (NASDAQ: NVAX) shares are trading lower Thursday following multiple significant announcements. Here's what you need to know. 
Via Benzinga
News headline image
Stocks Edge Up As Producer Inflation Supports Rate Cut Bets, Small Caps, Miners Rally: What's Driving Markets Thursday? ↗
At midday on Thursday, Wall Street was showing slight gains, with small caps leading the charge. The Russell 2000 index surged 1.2%, outperforming large-cap indices in a notable rebound. 
Via Benzinga
Topics Economy
News headline image
Moderna Outlines Post-Covid Roadmap, Cuts Research Budget, Forecasts 2025 Sales Below Expectations ↗
Moderna highlights its mRNA pipeline and financial strategy at R&D Day and aims for 10 product approvals by 2027, expects to reduce R&D spending by $1.1 billion, and projects profitability for its... 
Via Benzinga
News headline image
Nasdaq, S&P 500 Set For Modest Gains As Investors Eye August Inflation Data And ECB Rate Decision ↗
U.S. stocks could open Thursday’s session modestly higher after the remarkable recovery they staged in the previous session. The spotlight is on the producer price inflation report for August as... 
Via Benzinga
Topics Economy Stocks
News headline image
Moderna To Slash $1.1 Billion From R&D Spending In Major Commercial Push ↗
The company says it's investment in R&D has paid off. Now, it needs to move its focus to launching new products. 
Via Investor's Business Daily
News headline image
3 No-Brainer Biotech Stocks to Buy With $200 Right Now ↗
An investment in these players today could score a big win down the road. 
Via The Motley Fool
News headline image
GSK Halts Herpes Simplex Virus Vaccine Development, Clears Path For Other Contenders Like Moderna, BioNTech ↗
GSK Plc has halted development of its herpes simplex virus vaccine, GSK3943104, after it failed to meet efficacy goals in clinical trials. Moderna and Pfizer's partner BioNTech are still developing HSV... 
Via Benzinga
News headline image
Is Hims & Hers Health the Next Teladoc? ↗
Telemedicine was one of the most in-demand services during the height of the COVID-19 pandemic. 
Via The Motley Fool
News headline image
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Moderna, Lululemon, XPEL, and Nano Nuclear and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
< Previous 1 2
...
24 25 26 27 28 29 30 31 32
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.